Latest filing published 06 Jan 2014 for Marina Biotech, Inc..
Insider track record
No signal scores available.
Philip C. Ranker: trading record in brief
Filings by Philip C. Ranker span 2 companies, the busiest being Marina Biotech, Inc. and Imarx Therapeutics Inc. Over a trading history stretching from 1 January 2006 to 1 January 2014, the count stands at 10 filings.
On the market, this insider has only sold: 1 sale, €25k in total. The rest of the record consists of 9 share grants.
The record was last updated on 6 January 2014 with a share grant in Marina Biotech, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Philip C. Ranker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 897,303 sharesCommon StockSEC:0001571049-14-000035:0
- 300,000 shares0Common StockSEC:0000893877-09-000314:0
- 23,810 shares0Common StockSEC:0001406497-08-000005:0
- 69 shares@ US$14.05Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-052751:0
- 1,321 shares@ US$14.02Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-050932:0
- 192 shares@ US$10.98Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-040823:0
- 12,000 shares0Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-008751:0
- 2,206 shares@ US$14.58Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-002472:0
- 20,133 shares0Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-001153:0
9 of 9 declarations